<DOC>
	<DOCNO>NCT01986114</DOCNO>
	<brief_summary>The study evaluate long-term efficacy safety SM-13496 patient bipolar I disorder .</brief_summary>
	<brief_title>A Long-Term Study SM-13496 Patients With Bipolar I Disorder .</brief_title>
	<detailed_description>The study objective evaluate long-term efficacy safety SM-13496 ( 20-120 mg/day ) patient bipolar I disorder .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<criteria>Patients complete D1002001 study ・Patients complete D1002001 study consider investigator eligible without safety concern . Patients participate D1002001 study Patients fully inform understand objective , procedure , possible benefit risk study provide write voluntary consent participate study . Outpatients age 18 74 year time consent Patients meet DSMIVTR criterion bipolar I disorder , recent episode manic , hypomanic , mixed without rapid cycle disease course ( ≥ 4 episode mood disturbance , &lt; 8 episode previous 12 month prior screen ) . Patients imminent risk suicide injury self , others , property . Patients otherwise consider ineligible study investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>